These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 21590308)
41. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Kwo PY; Cohen SM; Lim JK Am J Gastroenterol; 2017 Jan; 112(1):18-35. PubMed ID: 27995906 [TBL] [Abstract][Full Text] [Related]
42. [The effect of the analgesic flupirtine on automobile driving]. Biehl B Arzneimittelforschung; 1985; 35(1):77-81. PubMed ID: 4039155 [TBL] [Abstract][Full Text] [Related]
43. Liver-specific deletion of Eva1a/Tmem166 aggravates acute liver injury by impairing autophagy. Lin X; Cui M; Xu D; Hong D; Xia Y; Xu C; Li R; Zhang X; Lou Y; He Q; Lv P; Chen Y Cell Death Dis; 2018 Jul; 9(7):768. PubMed ID: 29991758 [TBL] [Abstract][Full Text] [Related]
44. Protection of CCL4-induced liver damage in rats by some calcium channel blockers. Singh J; Kaur AH; Mathur SK Indian J Physiol Pharmacol; 1995 Jul; 39(3):275-8. PubMed ID: 8550125 [TBL] [Abstract][Full Text] [Related]
45. Specificity of transaminase activities in the prediction of drug-induced hepatotoxicity. Kobayashi A; Suzuki Y; Sugai S J Toxicol Sci; 2020; 45(9):515-537. PubMed ID: 32879252 [TBL] [Abstract][Full Text] [Related]
46. Acute submassive hepatic necrosis due to methyldopa. A case demonstrating possible initiation of chronic liver disease. Schweitzer IL; Peters RL Gastroenterology; 1974 Jun; 66(6):1203-11. PubMed ID: 4133500 [No Abstract] [Full Text] [Related]
47. [Hepatic histopathological aspects and humoral findings in drug addicts: critical considerations on 37 cases]. Bartoloni Saint Omer F; Montalto B; Chibaro G; Manfredini F Recenti Prog Med; 1979 Jul; 67(1):70-88. PubMed ID: 542712 [No Abstract] [Full Text] [Related]
48. Chronic administration of fluoxetine or clozapine induces oxidative stress in rat liver: a histopathological study. Zlatković J; Todorović N; Tomanović N; Bošković M; Djordjević S; Lazarević-Pašti T; Bernardi RE; Djurdjević A; Filipović D Eur J Pharm Sci; 2014 Aug; 59():20-30. PubMed ID: 24768740 [TBL] [Abstract][Full Text] [Related]
49. MRI-based preclinical discovery of DILI: A lesson from paracetamol-induced hepatotoxicity. Grudzinski IP; Ruzycka M; Cieszanowski A; Szeszkowski W; Badurek I; Malkowska A; Bamburowicz-Klimkowska M Regul Toxicol Pharmacol; 2019 Nov; 108():104478. PubMed ID: 31539568 [TBL] [Abstract][Full Text] [Related]
50. Clinical Features of Drug-induced Liver Injury According to Etiology. Lee BM; Lee WC; Jang JY; Ahn P; Kim JN; Jeong SW; Park EJ; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Kim HS; Kim BS J Korean Med Sci; 2015 Dec; 30(12):1815-20. PubMed ID: 26713057 [TBL] [Abstract][Full Text] [Related]
51. Structure-Activity Relationships of Flupirtine Analogues for Liver Esterase-Mediated Cleavage of the 4-Fluorobenzylamine Moiety and Its Possible Relevance to Liver Toxicity. Beirow K; Jedamzik J; Schulig L; Wurm KW; Lemmerhirt CJ; Hofstetter RK; Link A; Bednarski PJ ChemMedChem; 2023 Jul; 18(14):e202300145. PubMed ID: 37170841 [TBL] [Abstract][Full Text] [Related]
52. In vitro approach to elucidate the relevance of carboxylesterase 2 and N-acetyltransferase 2 to flupirtine-induced liver injury. Konishi K; Fukami T; Ogiso T; Nakajima M Biochem Pharmacol; 2018 Sep; 155():242-251. PubMed ID: 30028988 [TBL] [Abstract][Full Text] [Related]
53. The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity. Robles-Diaz M; Garcia-Cortes M; Medina-Caliz I; Gonzalez-Jimenez A; Gonzalez-Grande R; Navarro JM; Castiella A; Zapata EM; Romero-Gomez M; Blanco S; Soriano G; Hidalgo R; Ortega-Torres M; Clavijo E; Bermudez-Ruiz PM; Lucena MI; Andrade RJ; ; Liver Int; 2015 Nov; 35(11):2474-82. PubMed ID: 25809419 [TBL] [Abstract][Full Text] [Related]
54. Severe idiosyncratic acute hepatic injury caused by paracetamol. Andrade RJ; Lucena MI; García-Escaño MD; Camargo R J Hepatol; 1998 Jun; 28(6):1078. PubMed ID: 9672188 [No Abstract] [Full Text] [Related]
55. The clinical features of drug-induced liver injury observed through liver biopsy: focus on relevancy to autoimmune hepatitis. Ju HY; Jang JY; Jeong SW; Woo SA; Kong MG; Jang HY; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Jin SY; Kim HS; Kim BS Clin Mol Hepatol; 2012 Jun; 18(2):213-8. PubMed ID: 22893872 [TBL] [Abstract][Full Text] [Related]
57. In silico modeling to optimize interpretation of liver safety biomarkers in clinical trials. Church RJ; Watkins PB Exp Biol Med (Maywood); 2018 Feb; 243(3):300-307. PubMed ID: 29096561 [TBL] [Abstract][Full Text] [Related]
58. Effects of Salmonella infection on hepatic damage following acute liver injury in rats. Li YT; Yu CB; Yan D; Huang JR; Li LJ Hepatobiliary Pancreat Dis Int; 2016 Aug; 15(4):399-405. PubMed ID: 27498580 [TBL] [Abstract][Full Text] [Related]
59. Histological and lipid peroxidation changes after administration of 2-acetylaminofluorene in a rat liver injury model following selective periportal and pericentral damage. Sigala F; Kostopanagiotou G; Andreadou I; Kavatzas N; Felekouras E; Sigalas P; Bastounis E; Papalambros E Toxicology; 2004 Mar; 196(1-2):155-63. PubMed ID: 15036765 [TBL] [Abstract][Full Text] [Related]